Initiating buprenorphine treatment for opioid use disorder during short-term in-patient ‘detoxification’: a randomized clinical trial
Salvato in:
Stein, M., et al., Initiating buprenorphine treatment for opioid use disorder during short-term in-patient ‘detoxification’: a randomized clinical trial. Addiction, vol. 115, n. 1, 2020, p. 82-96.
Ref.
573532
Localizzazione:
SIIS Archivo (R.696)
Palabras clave:
Drogodependencias, Drogas ilegales, Opiáceos, Desintoxicación, Tratamiento, Servicios de salud, Atención primaria, Alta médica, Buprenorfina, Programas de mantenimiento, Efectos, EE.UU.
Drogodependencias, Drogas ilegales, Opiáceos, Desintoxicación, Tratamiento, Servicios de salud, Atención primaria, Alta médica, Buprenorfina, Programas de mantenimiento, Efectos, EE.UU.
Documenti analoghi: Initiating buprenorphine treatment for opioid use disorder during short-term in-patient ‘detoxification’: a randomized clinical trial
- OPEN-LABEL TRIAL OF AN INJECTION DEPOT FORMULATION OF BUPRENORPHINE IN OPIOID DETOXIFICATION
- PREDICTORS OF DISCHARGES AGAINST MEDICAL ADVICE FROM A SHORT-TERM HOSPITAL DETOXIFICATION UNIT
- A MULTI-CENTER RANDOMIZED TRIAL OF BUPRENORPHINE-NALOXONE VERSUS CLONIDINE FOR OPIOID DETOXIFICATION: FINDINGS FROM THE NATIONAL INSTITUTE ON DRUG ABUSE CLINICAL TRIALS NETWORK
- OPIOID DETOXIFICATION USING HIGH DOSES OF BUPRENORPHINE IN 24 HOURS: A RANDOMIZED, DOUBLE BLIND, CONTROLLED CLINICAL TRIAL
- PREDICTORS OF OUTCOME FOR SHORT-TERM MEDICALLY SUPERVISED OPIOID WITHDRAWAL DURING A RANDOMIZED, MULTICENTER TRIAL OF BUPRENORPHINE-NALOXONE AND CLONIDINE IN THE NIDA CLINICAL TRIALS NETWORK DRUG AND ALCOHOL DEPENDENCE
- PAIN AND CONTINUED OPIOID USE IN INDIVIDUALS RECEIVING BUPRENORPHINE-NALOXONE FOR OPIOID DETOXIFICATION: SECONDARY ANALYSES FROM THE CLINICAL TRIALS NETWORK